NCT06836037 A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011) Status COMPLETED Phase PHASE1
NCT06833879 Activity Tracking Study in Healthy Volunteers (MK-0000-419) Status COMPLETED Phase PHASE1
NCT06833073 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) Status RECRUITING Phase PHASE2
NCT06829225 Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) Status COMPLETED Phase PHASE1
NCT06829199 A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003) Status WITHDRAWN Phase PHASE2
NCT06826989 A Study of MK-8527 in Healthy Adult Participants (MK-8527-013) Status COMPLETED Phase PHASE1
NCT06824467 A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) Status RECRUITING Phase PHASE3
NCT06822543 A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer) Status RECRUITING Phase PHASE2
NCT06821334 A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014) Status COMPLETED Phase PHASE1
NCT06818968 A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005) Status COMPLETED Phase PHASE1
NCT06818643 A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002) Status RECRUITING Phase PHASE1/PHASE2
NCT06816043 A Study of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) and MK-8527 in Healthy Participants Status COMPLETED Phase PHASE1
NCT06816030 A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009) Status COMPLETED Phase PHASE1
NCT06814145 Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) Status RECRUITING Phase PHASE2
NCT06814132 A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010) Status COMPLETED Phase PHASE1
NCT06814119 A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010) Status COMPLETED Phase PHASE1
NCT06814106 A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010) Status COMPLETED Phase PHASE1
NCT06811246 A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058) Status COMPLETED Phase PHASE1
NCT06809569 A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420) Status COMPLETED Phase PHASE1
NCT06809140 Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer Status RECRUITING Phase PHASE2